PMCB PharmaCyte Biotech Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

PMCB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PMCB
(Try 14 days for Free)

View a ticker or compare two or three

Compare

PMCB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PMCB
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

PMCB is expected to report earnings to rise 125.00% to -9 cents per share on June 28

PharmaCyte Biotech PMCB Stock Earnings Reports

Q2'23

Est.

$-0.09

Q1'23

Beat

by $0.04

Q4'22

Missed

by $0.01

Q3'22

Est.

$-0.07

Q2'22

Missed

by $0.03

The last earnings report on March 14 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 13.85K shares outstanding, the current market capitalization sits at 11.42M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3960 Howard Hughes Parkway

Phone

+1 917 595-2850

Employees

Web

https://pharmacyte.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	29.82	0.82	+2.83%
GameStop Corp
AAPL	254.49	4.70	+1.88%
Apple
SPY	591.15	7.02	+1.20%
SPDR® S&P 500® ETF Trust
BTC.X	97224.730000	-531.203100	-0.54%
Bitcoin cryptocurrency
TSLA	421.06	-15.11	-3.46%
Tesla

PMCB and Stocks

Correlation & Price change

A.I.dvisor tells us that PMCB and ELVN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCB and ELVN's prices will move in lockstep.

Ticker / NAME	Correlation To PMCB	1D Price Change %
PMCB	100%	N/A
ELVN - PMCB	28% Poorly correlated	-1.75%
SER - PMCB	22% Poorly correlated	+8.41%
CRSP - PMCB	22% Poorly correlated	+0.83%
DYAI - PMCB	22% Poorly correlated	-8.14%
ATOS - PMCB	21% Poorly correlated	-1.66%
More